{"id":46657,"date":"2022-07-27T22:02:21","date_gmt":"2022-07-27T20:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/"},"modified":"2022-07-27T22:02:21","modified_gmt":"2022-07-27T20:02:21","slug":"xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/","title":{"rendered":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022"},"content":{"rendered":"
\n

MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022.\n<\/p>\n

<\/a><\/p>\n

\nXencor management will host a webcast and conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results and provide a corporate update.\n<\/p>\n

\nThe live webcast will be available under “Events & Presentations” in the Investors section of the Company’s website located at investors.xencor.com<\/a> and will be archived for at least 30 days. Participants may register for the conference call at the following link: register.vevent.com\/register\/BI8b3886bf9772414c8dd5900d3aa4457b<\/a>.\n<\/p>\n

\nAbout Xencor, Inc.<\/b>\n<\/p>\n

\nXencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor’s XmAb\u00ae<\/sup> technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor’s XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCharles Liles
\n
cliles@xencor.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022. Xencor management will host a webcast and conference call the same day at … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46657","6":"format-standard","7":"category-industry"},"yoast_head":"\nXencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022. Xencor management will host a webcast and conference call the same day at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-27T20:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022\",\"datePublished\":\"2022-07-27T20:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/\"},\"wordCount\":219,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220727005918\\\/en\\\/1222964\\\/21\\\/Xencor_logo_BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/\",\"name\":\"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220727005918\\\/en\\\/1222964\\\/21\\\/Xencor_logo_BW.jpg\",\"datePublished\":\"2022-07-27T20:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220727005918\\\/en\\\/1222964\\\/21\\\/Xencor_logo_BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220727005918\\\/en\\\/1222964\\\/21\\\/Xencor_logo_BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/","og_locale":"en_US","og_type":"article","og_title":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend","og_description":"MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022. Xencor management will host a webcast and conference call the same day at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-27T20:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022","datePublished":"2022-07-27T20:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/"},"wordCount":219,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/","url":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/","name":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg","datePublished":"2022-07-27T20:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220727005918\/en\/1222964\/21\/Xencor_logo_BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/xencor-to-host-second-quarter-2022-financial-results-webcast-and-conference-call-on-august-3-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46657"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46657\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}